Page last updated: 2024-11-12

erastin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

erastin: an antineoplastic agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

erastin : A member of the class of quinazolines that is quinazolin-4(3H)-one in which the hydrogens at positions 2 and 3 are replaced by 1-{4-[(4-chlorophenoxy)acetyl]piperazin-1-yl}ethyl and 2-ethoxyphenyl groups, respectively. It is an inhibitor of voltage-dependent anion-selective channels (VDAC2 and VDAC3) and a potent ferroptosis inducer. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11214940
CHEMBL ID401989
CHEBI ID94287
SCHEMBL ID4457820
MeSH IDM0453705

Synonyms (46)

Synonym
2-[1-[4-[2-(4-chlorophenoxy)acetyl]piperazin-1-yl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4-one
CHEMBL401989
erastin
BRD-A25004090-001-01-9
BRD-A25004090-001-02-7
BRD-A25004090-001-06-8
bdbm50376126
2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3h)-quinazolinone
571203-78-6
S7242
HY-15763
CS-1675
2-(1-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4(3h)-one
SCHEMBL4457820
AKOS025147365
4(3h)-quinazolinone, 2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-
AC-35446
mfcd09837984
EX-A295
DTXSID80458949
CHEBI:94287
erastin, >=98% (hplc)
HMS3653K21
C21478
NCGC00351608-14
NCGC00351608-10
SW208651-2
FT-0700333
Q27166099
2-[1-[4-[2-(4-chlorophenoxy)-1-oxoethyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4-quinazolinone
erastin - cas 571203-78-6
BCP27907
SB19588
HMS3868M03
CCG-269987
AS-55898
A869751
WXA20378
2-(1-(4-(2-(4-chlorophenoxy)acetyl)piperazin-1-yl)ethyl)-3-(2-ethoxyphenyl)quinazolin-4-one
zja3ns42t9 ,
piperazine, 1-((4-chlorophenoxy)acetyl)-4-(1-(3-(2-ethoxyphenyl)-3,4-dihydro-4-oxo-2-quinazolinyl)ethyl)-
e-7781
e7781
2-(1-(4-(2-(4-chlorophenoxy)acetyl)-1-piperazinyl)ethyl)-3-(2-ethoxyphenyl)-4(3h)-quinazolinone
2-[1-[4-[2-(4-chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)quinazolin-4(3h)-one
SY345515

Research Excerpts

Overview

Erastin is a low molecular weight chemotherapy drug that induces ferroptosis. It has shown promising cytotoxic effects in various types of cancers, including NSCLC.

ExcerptReferenceRelevance
"Erastin is a small molecule identified in chemical screen that is capable of inducing ferropotosis. "( Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis.
Cang, W; Gu, L; Qiu, L; Tian, Q; Wang, W; Wu, A; Zheng, Z, 2022
)
3.61
"Erastin is a low molecular weight chemotherapy drug that induces ferroptosis; however, poor water solubility and renal toxicity have limited its application."( Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Ding, D; Gai, C; Li, W; Li, Z; Lv, S; Yu, M; Zhang, W; Zheng, J, 2019
)
1.52
"Erastin is a ferroptosis inducer that has shown promising cytotoxic effects in various types of cancers, including NSCLC."( Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis.
Cao, P; Chang, Y; Chen, F; Fan, Y; Han, B; Han, Y; Huang, L; Li, D; Liu, M; Liu, T; Meng, Y; Nakai, A; Song, Z; Tan, K, 2021
)
1.67
"Erastin is a small molecule capable of initiating ferroptotic cell death in cancer cells, which has shown great potential for cancer therapy."( Erastin‑induced ferroptosis causes physiological and pathological changes in healthy tissues of mice.
Du, H; Feng, Y; Xiong, Q; Xu, B; Zhao, J, 2021
)
2.79

Actions

ExcerptReferenceRelevance
"Erastin@FA-exo could increase the uptake efficiency of erastin into MDA-MB-231 cells; compared with erastin@exo and free erastin, erastin@FA-exo has a better inhibitory effect on the proliferation and migration of MDA-MB-231 cells."( Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Ding, D; Gai, C; Li, W; Li, Z; Lv, S; Yu, M; Zhang, W; Zheng, J, 2019
)
1.52

Treatment

Treatment with erastin led to a significant increase in nitric oxide production. Erastin induced ferroptosis and decreased the concentration of glutathione and GPX4 protein expression levels.

ExcerptReferenceRelevance
"Erastin treatment induces DDR2 upregulation and phosphorylation, independent of collagen I."( DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
Alvarez, JV; Chen, PH; Chi, JT; Ding, CC; Lin, CC; Lin, YT; Qu, DC; Tang, X; Yang, WH, 2021
)
1.34
"Treatment with erastin led to a significant increase in inducible nitric oxide synthase (iNOS)-mediated nitric oxide production, which contributes to the accumulation of the death-inducing cellular lipid ROS."( Mechanism of Erastin-Induced Ferroptosis in MDA-MB-231 Human Breast Cancer Cells: Evidence for a Critical Role of Protein Disulfide Isomerase.
Wang, H; Wang, P; Zhu, BT, 2022
)
1.43
"Treatment with erastin induced ferroptosis and decreased the concentration of glutathione and GPX4 protein expression levels in the two tumor cell lines."( Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo.
Higashikawa, K; Kuge, Y; Miyamoto, N; Shibata, Y; Yasui, H, 2019
)
2.3
"Treatment with erastin and RSL3 led to a significant decrease in prostate cancer cell growth and migration"( Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer.
Aslan, M; Brooks, JD; Corey, E; Ghoochani, A; Hsu, EC; Nguyen, HM; Paulmurugan, R; Rice, MA; Stoyanova, T, 2021
)
0.96

Compound-Compound Interactions

The study is the first to report enhanced cytotoxicity of etoposide, in combination with erastin, in ER-positive breast cancer cells via activation of ferroptotic pathways. The study offers a new perspective for future regimens.

ExcerptReferenceRelevance
" In the present study, the effect of etoposide in combination with a ferroptotic agent, erastin, was investigated in breast cancer."( Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells.
Bakar-Ates, F; Ozkan, E, 2023
)
1.42
"In conclusion, this is the first study that reports enhanced cytotoxicity of etoposide, in combination with erastin, in ER-positive breast cancer cells via activation of ferroptotic pathways, and offers a new perspective for future regimens."( Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells.
Bakar-Ates, F; Ozkan, E, 2023
)
1.41

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" As low solubility of erastin limits its efficient application, we further prepared folate (FA)-modified liposome (FA-LP) nanoparticles for targeted co-delivery of erastin and MT1DP to enhance the bioavailability and the efficiency of the drug/gene combination."( MT1DP loaded by folate-modified liposomes sensitizes erastin-induced ferroptosis via regulating miR-365a-3p/NRF2 axis in non-small cell lung cancer cells.
Gai, C; Li, W; Liu, C; Lv, S; Wu, X; Yu, M; Zhang, W; Zheng, J, 2020
)
1.12

Dosage Studied

ExcerptRelevanceReference
" The dosing time-dependency of erastin-induced cystine/cysteine deprivation was closely related to that of its anti-tumor effects."( Dosing Time-Dependent Changes in the Anti-tumor Effect of xCT Inhibitor Erastin in Human Breast Cancer Xenograft Mice.
Koyanagi, S; Kusunose, N; Matsunaga, N; Ohdo, S; Shiromizu, S; Yamauchi, T, 2019
)
1.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
ferroptosis inducerAny substance that induces or promotes ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
voltage-dependent anion channel inhibitorAny agent that inhibits voltage-dependent anion channels.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (7)

ClassDescription
quinazolinesAny organic heterobicyclic compound based on a quinazoline skeleton and its substituted derivatives.
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
N-acylpiperazine
N-alkylpiperazine
dietherA polyether in which the number of ether linkages is 2.
tertiary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a secondary amine; formula RC(=O)NHR(1)R(2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Ferroptosis133

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency0.33790.01237.983543.2770AID1645841
GVesicular stomatitis virusPotency13.45040.01238.964839.8107AID1645842
Interferon betaHomo sapiens (human)Potency13.45040.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency13.45040.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency13.45040.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency13.45040.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cystine/glutamate transporterHomo sapiens (human)IC50 (µMol)0.18000.14001.14005.0000AID1252343; AID1534337; AID1534338
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Voltage-dependent anion-selective channel protein 2Homo sapiens (human)Kd0.10000.10000.10000.1000AID327395
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
HRAS, partialHomo sapiens (human)AC504.76000.287011.663968.0100AID540314; AID540315; AID540316
interferon gamma precursorHomo sapiens (human)AC507.75000.128015.173038.6100AID1259418
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (85)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
monoatomic anion transportVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
binding of sperm to zona pellucidaVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
negative regulation of protein polymerizationVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
mitochondrial outer membrane permeabilizationVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
monoatomic anion transmembrane transportVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
glutathione metabolic processCystine/glutamate transporterHomo sapiens (human)
visual learningCystine/glutamate transporterHomo sapiens (human)
response to toxic substanceCystine/glutamate transporterHomo sapiens (human)
response to organic cyclic compoundCystine/glutamate transporterHomo sapiens (human)
L-cystine transportCystine/glutamate transporterHomo sapiens (human)
L-glutamate transmembrane transportCystine/glutamate transporterHomo sapiens (human)
ventricular system developmentCystine/glutamate transporterHomo sapiens (human)
striatum developmentCystine/glutamate transporterHomo sapiens (human)
adult behaviorCystine/glutamate transporterHomo sapiens (human)
regulation of neutrophil apoptotic processCystine/glutamate transporterHomo sapiens (human)
cellular response to oxidative stressCystine/glutamate transporterHomo sapiens (human)
glutathione transmembrane transportCystine/glutamate transporterHomo sapiens (human)
response to nicotineCystine/glutamate transporterHomo sapiens (human)
regulation of cell population proliferationCystine/glutamate transporterHomo sapiens (human)
regulation of melanin biosynthetic processCystine/glutamate transporterHomo sapiens (human)
lung alveolus developmentCystine/glutamate transporterHomo sapiens (human)
modulation of chemical synaptic transmissionCystine/glutamate transporterHomo sapiens (human)
regulation of synapse organizationCystine/glutamate transporterHomo sapiens (human)
regulation of protein transportCystine/glutamate transporterHomo sapiens (human)
response to redox stateCystine/glutamate transporterHomo sapiens (human)
limb developmentCystine/glutamate transporterHomo sapiens (human)
lens fiber cell differentiationCystine/glutamate transporterHomo sapiens (human)
platelet aggregationCystine/glutamate transporterHomo sapiens (human)
intracellular glutamate homeostasisCystine/glutamate transporterHomo sapiens (human)
L-glutamate import across plasma membraneCystine/glutamate transporterHomo sapiens (human)
negative regulation of ferroptosisCystine/glutamate transporterHomo sapiens (human)
dipeptide import across plasma membraneCystine/glutamate transporterHomo sapiens (human)
L-kynurenine transmembrane transportCystine/glutamate transporterHomo sapiens (human)
regulation of cellular response to oxidative stressCystine/glutamate transporterHomo sapiens (human)
regulation of cysteine metabolic processCystine/glutamate transporterHomo sapiens (human)
regulation of glutathione biosynthetic processCystine/glutamate transporterHomo sapiens (human)
regulation of AMPA glutamate receptor clusteringCystine/glutamate transporterHomo sapiens (human)
regulation of glutamate metabolic processCystine/glutamate transporterHomo sapiens (human)
amino acid transmembrane transportCystine/glutamate transporterHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (28)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
nucleotide bindingVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
protein bindingVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
oxysterol bindingVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
voltage-gated monoatomic anion channel activityVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
porin activityVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
cholesterol bindingVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
phosphatidylcholine bindingVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
ceramide bindingVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingCystine/glutamate transporterHomo sapiens (human)
cystine:glutamate antiporter activityCystine/glutamate transporterHomo sapiens (human)
L-kynurenine transmembrane transporter activityCystine/glutamate transporterHomo sapiens (human)
L-amino acid transmembrane transporter activityCystine/glutamate transporterHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (33)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
acrosomal vesicleVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
nucleusVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
mitochondrionVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
mitochondrial outer membraneVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
membraneVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
mitochondrial membraneVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
mitochondrial nucleoidVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
sperm midpieceVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
pore complexVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
mitochondrial outer membraneVoltage-dependent anion-selective channel protein 2Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
plasma membraneCystine/glutamate transporterHomo sapiens (human)
cell surfaceCystine/glutamate transporterHomo sapiens (human)
membraneCystine/glutamate transporterHomo sapiens (human)
brush border membraneCystine/glutamate transporterHomo sapiens (human)
microvillus membraneCystine/glutamate transporterHomo sapiens (human)
apical part of cellCystine/glutamate transporterHomo sapiens (human)
astrocyte projectionCystine/glutamate transporterHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (100)

Assay IDTitleYearJournalArticle
AID1252341Selectivity ratio of IC50 for human BJeH cells to IC50 for human RAS-G12V overexpressing BJeLR cells2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID327334Induction of pro-caspase 3 cleavage in human HT1080 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327375Induction of cell death in human HCT116 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327344Induction of cell death in human SK-ES-1 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327341Induction of cell death in TERT expressing human BJ cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327338Induction of cell death in human A673 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327372Induction of cell death in human LNCaP cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID702310Induction of reactive oxygen species production in human BJeH cells expressing wild type RAS after 6 hrs by DCF-based flow cytometric analysis2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.
AID327347Induction of cell death in human TC32 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327395Binding affinity to human VDAC22007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327340Induction of cell death in human EWS502 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327365Induction of cell death in human MES-SA cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327339Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327360Effect on ERK1/2 phosphorylation in human TC71 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1252333Solubility of compound in water2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID327319Prevention of induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells after 24 hrs in presence of butylated hydroxytoluene2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327324Suppression of induction of cell death in human HT1080 cells at 5 mM by Alamar Blue assay in presence of glutathione2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327320Prevention of induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells after 24 hrs in presence of alpha-tocopherol2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID702292Cytotoxicity against human BJeLR cells expressing RAS G12V mutant at 10 uM at 24 hrs by trypan blue staining2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.
AID327345Induction of cell death in human SK-N-MC cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327346Induction of cell death in human SW872 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327390Induction of cell death in human HT1080 cells in presence of MEK inhibitor 2 by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327366Induction of cell death in human U2OS cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327364Induction of cell death in human SKLMS1 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327330Induction of PARP1 cleavage in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells after 14 hrs2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327368Induction of cell death in human Hs51.T cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327363Induction of cell death in human SJSA1 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID702298Cytotoxicity against human BJeH cells expressing wild type RAS at 10 uM after 24 hrs by trypan blue staining2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.
AID327362Induction of cell death in human HOS cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327388Induction of cell death in human HT1080 cells in presence of PD-98059 by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327377Induction of cell death in human A431NS cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327349Induction of cell death in human U937 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327357Effect on ERK1/2 phosphorylation in human SK-NM-C cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1252344Growth inhibition of human RAS-G12V overexpressing DRD cells after 48 hrs by alamar blue assay2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID1534338Inhibition of cystine/glutamate antiporter system xc- in human Calu1 cells assessed as reduction in L-[3,3'-14C]-cystine uptake in presence of Na+ free uptake buffer by scintillation counting assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Discovery and development of small molecule modulators targeting glutamine metabolism.
AID1252334Half life in mouse liver microsomes by LC-MS/MS analysis2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID327354Effect on ERK1/2 phosphorylation in human HL60 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327321Prevention of induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells after 24 hrs in presence of beta-carotene2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327359Effect on ERK1/2 phosphorylation in human TC32 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327387Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells in presence of PD-98059 by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327386Induction of cell death in human HT1080 cells in presence of MEK 1/2 inhibitor by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327376Induction of cell death in human SW982 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327385Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells in presence of MEK 1/2 inhibitor by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327322Increase in intracellular oxidative species in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells at 4.6 uM2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327371Induction of cell death in human MX2 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1905090Induction of cell death in human A549 cells assessed as vanished mitochondrial cristae at 10 uM for 12 hrs by TEM analysis2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID327335Induction of pro-caspase 3 cleavage in human HeLa cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327352Effect on ERK1/2 phosphorylation in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327336Induction of pro-caspase 3 cleavage in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327370Induction of cell death in human SKUT cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1723851Induction of ferroptosis in human MIA PaCa-2 cells assessed as increase in lipid peroxidation at 20 to 40 uM measured after 24 hrs by C11-BODIPY dye based fluorescence assay2020Journal of medicinal chemistry, 09-10, Volume: 63, Issue:17
A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species.
AID702291Cytotoxicity against human BJeLR cells expressing RAS G12V mutant at 10 uM at 12 hrs by trypan blue staining2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.
AID1905030Induction of cell death in human A549 cells assessed as increased mitochondrial membrane density at 10 uM for 12 hrs by TEM analysis2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID327350Effect on ERK1/2 phosphorylation in human A673 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327383Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes in presence of MEK inhibitor by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1534337Inhibition of cystine/glutamate antiporter system xc- in human HT1080 cells assessed as reduction in L-[3,3'-14C]-cystine uptake in presence of Na+ free uptake buffer by scintillation counting assay2019European journal of medicinal chemistry, Feb-01, Volume: 163Discovery and development of small molecule modulators targeting glutamine metabolism.
AID327367Induction of cell death in human HeLa cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327328Induction of PARP1 cleavage in human HT1080 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327332Induction of cytochrome c release in cytosolic fraction of human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes at 20 ug/ml2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327373Induction of cell death in human C33A cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327361Effect on ERK1/2 phosphorylation in human U937 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327353Effect on ERK1/2 phosphorylation in human EWS502 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID702311Induction of reactive oxygen species production in human BJeLR cells expressing RAS G12V mutant after 6 hrs by DCF-based flow cytometric analysis2012Bioorganic & medicinal chemistry letters, Sep-01, Volume: 22, Issue:17
Design and synthesis of Pictet-Spengler condensation products that exhibit oncogenic-RAS synthetic lethality and induce non-apoptotic cell death.
AID327343Induction of cell death in human HT1080 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1905126Invivo antitumor activity against human A549 cells xenografted in athymic nude BALB/c mouse assessed as tumor weight at 10 mg/kg measured after 30 days (Rvb = 1 gram)2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID327337Inhibition of human Calu1 cells expressing KRAS with activating mutations by trypan blue exclusion assay2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1252332Growth inhibition of human RAS-G12V overexpressing BJeLR cells2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID327391Induction of mitochondrial structural integrity loss in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells at 37 uM after 10 hrs2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327380Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes at 13 uM2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327369Induction of cell death in human Hs925.T cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1252343Inhibition of Xct in human CCF-STTG1 cells assessed as glutamate release after 2 hrs by fluorometry2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID1905094Induction of ferroptosis in human A549 cells assessed as depletion of GSH levels at 10 uM upto 12 hrs2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID327351Effect on ERK1/2 phosphorylation in TERT expressing human BJ cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1905128Invivo antitumor activity against human A549 cells xenografted in athymic nude BALB/c mouse assessed as tumor growth inhibition at 10 mg/kg measured after 30 days relative to control2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID327329Induction of PARP1 cleavage in human HeLa cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327384Induction of cell death in human HT1080 cells in presence of MEK inhibitor by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327382Induction of cell death in human HT1080 cells in presence of U0126 by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327327Induction of PARP1 cleavage in human A673 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327374Induction of cell death in human SVR cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327348Induction of cell death in human TC71 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327326Suppression of induction of cell death in human HT1080 cells at 5 mM by Alamar Blue assay in presence of in presence of alpha-tocopherol2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327358Effect on ERK1/2 phosphorylation in human SW872 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327356Effect on ERK1/2 phosphorylation in human SKES1 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327381Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes in presence of U0126 by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327333Induction of pro-caspase 3 cleavage in human A673 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327342Induction of cell death in human HL60 cells2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327331Induction of cytochrome c release in mitochondrial fraction of human BJ cell expressing TERT, LT, ST and RAS G12V mutant genes at 20 ug/ml2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327318Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells at 9 uM2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327325Suppression of induction of cell death in human HT1080 cells at 5 mM by Alamar Blue assay in presence of butylated hydroxytoluene2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID327355Effect on ERK1/2 phosphorylation in human HT1080 cells by Western blot2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1252342Growth inhibition of human RAS-G12V overexpressing BJeLR cells after 48 hrs by alamar blue assay2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
Incorporation of metabolically stable ketones into a small molecule probe to increase potency and water solubility.
AID327323Effect on intracellular oxidative species in TERT expressing human BJ cells at 4.6 uM2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1905127Invivo antitumor activity against human A549 cells xenografted in athymic nude BALB/c mouse assessed as tumor volume at 10 mg/kg measured after 30 days (Rvb = 1503.3 mm^3)2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery of a Novel Stilbene Derivative as a Microtubule Targeting Agent Capable of Inducing Cell Ferroptosis.
AID327389Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells in presence of MEK inhibitor 2 by trypan blue exclusion method2007Nature, Jun-14, Volume: 447, Issue:7146
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (208)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (2.40)29.6817
2010's83 (39.90)24.3611
2020's120 (57.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.11 (24.57)
Research Supply Index5.36 (2.92)
Research Growth Index6.45 (4.65)
Search Engine Demand Index76.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews9 (4.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other203 (95.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]